1 completed, 1 terminated. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Terminated 1 |
Follow sabizabulin: new trials by email Literature Review of sabizabulin trials Research Report on sabizabulin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy Evaluation of VERU-111 for mCRPC in Patients Who Have Failed at Least One Androgen Receptor Targeting Agent VERU-111, Enzalutamide, Abiraterone - Metastatic Castration-resistant Prostate Cancer, Androgen Resistant Prostatic Cancer | Phase 3 | Terminated | Veru Inc. | 105 | 2021-06-24 | 2024-02-05 |
| VERU-111 in the Treatment of SARS-Cov-2 Infection by Assessing Its Effect on the Proportion of Patients Who Die on Study VERU-111 - SARS-CoV Infection | Phase 3 | Completed | Veru Inc. | 204 | 2021-05-18 | 2026-09-10 |
Prostatic Neoplasms, Castration-Resistant (1) · Severe Acute Respiratory Syndrome (1)
Veru Inc. (2)
United States (2) · Argentina (1) · Brazil (1) · Bulgaria (1) · Colombia (1) · Mexico (1)